The characterization and antibiotic resistance profiles of clinical Escherichia coli O25b-B2-ST131 isolates in Kuwait

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Dashti, Ali A ^a   Vali, Leila ^a   El Shazly, Sherief ^a   Jadaon, Mehrez M ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Escherichia coli ST131; Extended spectrum beta lactamases; Pulsed field gel electrophoresis; QnrB

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; BETA LACTAMASE CMY 2; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M15; BETA LACTAMASE CTX M2; BETA LACTAMASE CTX M56; BETA LACTAMASE IMP; BETA LACTAMASE NDM; BETA LACTAMASE VIM; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; QNRA PROTEIN; QNRB PROTEIN; QNRB1 PROTEIN; QNRS PROTEIN; SULTAMICILLIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BROTH DILUTION; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN; KUWAIT; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PLASMID; POPULATION GENETICS; PULSED FIELD GEL ELECTROPHORESIS; ADOLESCENT; ADULT; ANALYSIS; CHILD; CLASSIFICATION; CLUSTER ANALYSIS; DRUG EFFECTS; ESCHERICHIA COLI INFECTION; FEMALE; GENETICS; GENOTYPE; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR TYPING; NEWBORN; PRESCHOOL CHILD; YOUNG ADULT;

ESCHERICHIA COLI;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; KUWAIT; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; PLASMIDS; YOUNG ADULT;

EID: 84908004153     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-014-0214-6     Document Type: Article

References (47)

1. Peirano G, Pitout JDD: Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010, 35:316-321.
2. Dahbi G, Mora A, López C, Alonso MP, Mamani R, Marzoa J, Coira A, García-Garrote F, Pita JM, Velasco D, Herrera A, Viso S, Blanco JE, Blanco M, Blanco J: Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum β-lactamases. Int J Antimicrob Agents 2013, 42:347-351. doi: 10.1016/j.ijantimicag.
3. Karisik E, Ellington MJ, Pike R, Warren RE, Livermore DM, Woodford N: Molecular characterization of plasmids encoding CTX-M-15 β-lactamases from Escherichia coli strains in the United States. J Antimicrob Chemother 2006, 58:665-668.
4. Lau SH, Kaufmann MK, Livermore DM, Woodford N, Willshaw GA, Cheasty T, Stamper K, Reddy S, Cheesbrough J, Bolton FJ, Fox AJ, Upton M: UK epidemic Escherichia coli strains A E, with CTX-M-15 β-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother 2008, 62:1241-1244.
5. Pitout JDD, Gregson DB, Campbell L, Laupland KB: Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary health region from 2000 to 2007: Emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 2007, 2009(53):2846-2851.
6. Johnson JR, Johnson B, Clabots C, Kuskowski MA, Pendyala S, DebRoy C, Nowicki B, Rice J: Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients. Antimicrob Agents Chemother 2010, 54:546-550.
7. Amyes SG, Walsh FM, Bradley JS: Best in class: a good principle for antibiotic usage to limit resistance development? J Antimicrob Chemother 2007, 59:825-826.
8. Pérez-Pérez FJ, Hanson ND: Detection of plasmid-mediated AmpC β-Lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
9. Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, López C, Cortés P, Llagostera M, Leflon-Guibout V, Puentes B, Mamani R, Herrera A, Coira MA, García-Garrote F, Pita JM, Blanco J: Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2009, 63:1135-1141.
10. Mora A, Herrera A, Mamani R, López C, Alonso MP, Blanco JE, Blanco M, Dahbi G, García-Garrote F, Pita JM, Coira A, Bernárdez MI, Blanco J: Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates. Appl Environ Microbiol 2010, 76:6991-6997.
11. Vetting MW, Hegde SS, Fajardo JE, Fiser A, Roderick SL, Takiff HE, Blanchard JS: Pentapeptide repeat proteins. Biochemistry 2006, 45:1-10.
12. Nordmann P, Poirel L: Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother 2005, 56:463-469.
13. Poirel L, Hombrouck-Alet C, Freneaux C, Bernabeu S, Nordmann P: Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis 2010, 10:832.
14. Woodford N, Turton JF, Livermore DM: Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 2011, 35:736-755.
15. Nordmann P, Poirel L, Carrer A, Toleman MA, Walsh TR: How to detect NDM-1 producers. J Clin Microbiol 2011, 49:718-721.
16. Mantengoli E, Luzzaro F, Pecile P, Cecconi D, Cavallo A, Attala L, Bartoloni A, Rossolini GM: Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options. Clin Infect Dis 2011, 52:690-691.
17. Jamal W, Rotimi VO, Albert MJ, Khodakhast F, Udo EE, Poirel L: Emergence of nosocomial New Delhi metallo-β-lactamase-1 (NDM-1)-producing Klebsiella pneumoniae in patients admitted to a tertiary care hospital in Kuwait. Int J Antimicrob Agents 2012, 39:183-184.
18. Dortet L, Poirel L, Al Yaqoubi F, Nordmann P: NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman. Clin Microbiol Infect 2012, 18:E144-E148.
19. Poirel L, Carbonnelle E, Bernabeu S, Gutmann L, Rotimi V, Nordmann P: Importation of OXA-48-producing Klebsiella pneumoniae from Kuwait. J Antimicrob Chemother 2012, 67:2051-2052.
20. Stolle I, Prenger-Berninghoff E, Stamm I, Scheufen S, Hassdenteufel E, Guenther S, Bethe A, Pfeifer Y, Ewers C: Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs. J Antimicrob Chemother 2013, 68:2802-2808.
21. Grisold AJ, Hoenigle M, Ovcina I, Valentin T, Fruhwald S: Ventilator-associated pneumonia caused by OXA-48-producing Escherichia coli complicated by ciprofloxacin-associated rhabdomyolysis. J Infect Chemother 2013, 19:1214-1217.
22. Zowawi HM, Balkhy HH, Walsh TR, Paterson DL: β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula. Clin Microbiol Rev 2013, 26:361-380.
23. Clermont O, Bonacorsi S, Bingen E: Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000, 66:4555-4558.
24. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, Boyd D, Mulvey MR, Nordmann P, Ruppé E, Sarthou JL, Frank T, Vimont S, Arlet G, Branger C, Woodford N, Denamur E: Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15 producing strains. J Antimicrob Chemother 2009, 64:274-277.
25. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. In Document M100-S21. Wayne, PA: CLSI; 2012.
26. Pitout JD, Gregson DB, Church DL, Laupland KB: Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary. Emerg Infect Dis 2007, 13:443-448.
27. Dashti AA, Jadaon MM, Gomaa HH, Noronha B, Udo EE: Transmission of a Klebsiella pneumoniae clone harbouring genes for CTX-M-15-like and SHV-112 enzymes in a neonatal intensive care unit of a Kuwaiti hospital. J Med Microbiol 2010, 59:687-692.
28. Sonnevend A, Al Dhaheri K, Mag T, Herpay M, Kolodziejek J, Nowotny N, Usmani A, Sheikh FA, Pal T: CTX-M-15-producing multidrug-resistant enteroaggregative Escherichia coli in the United Arab Emirates. Clin Microbiol Infect 2006, 12:582-585.
29. Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P: Multiplex PCR for detection of plasmid-medicated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 2007, 60:394-397.
30. Cattoir V, Weill FX, Poirel L, Fabre L, Soussy CJ, Nordmann P: Prevalence of qnr genes in Salmonella in France. J Antimicrob Chemother 2007, 59:751-5744.
31. Park CH, Rovicsek A, Jacoby GA, Sahm D, Hooper DC: Prevalence in the United States of aac(6)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2006, 50:3953-3955.
32. Mammeri H, Van De Loo M, Poirel L, Martinez-Martinez L, Nordmann P: Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother 2005, 49:71-76.
33. Giraud E, Brisabois A, Martel JL, Chaslus-Dancla EP: Comparative study of mutations in animal isolates and experimental in-vitro and in-vivo mutation of Salmonella spp. suggests a counter selection of highly fluoroquinolone resistant strains in the field. Antimicrob Agents Chemother 1999, 43:2131-2137.
34. Mazel D, Dychinco B, Webb VA, Davies J: Antibiotic resistance in the ECOR collection: Integrons and identification of a novel aad gene. Antimicrob Agents Chemother 2000, 44:1568-1574.
35. Sánez Y, Briñas L, Domínguez E, Zarazaga M, Vila J, Torres C: Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins. Antimicrob Agents Chemother 2004, 48:3996-4001.
36. Kiratisin P, Apisarnthanarak A, Saifon P, Laesripa C, Kitphati R, Mundy LM: The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum beta-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand. Diagn Microbiol Infect Dis 2007, 58:349-355.
37. Ribot FM, Fair NA, Gautom R, Carmeron DN, Hunter SB, Swaminathan B, Barrett TJ: Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157, Salmonella and Shigella for pulsenet. Foodborne Pathog Dis 2006, 3:59-67.
38. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ: Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005, 63:219-228.
39. Mshana SE, Imirzalioglu C, Hossain H, Hain T, Domann E, Chakraborty T: Conjugative IncFI plasmids carrying CTX-M-15 among Escherichia coli ESBL producing isolates at a University hospital in Germany. BMC Infect Dis 2009, 9:97. doi:10.1186/1471-2334-9-97.
40. Khan MA, Lemmens N, Riera E, Blonk T, Goedhart J, Van Belkum A, Goessens W, Hays JP, Van Westreenen M: Dominance of CTX-M-2 and CTX-M-56 among extended-spectrum β-lactamases produced by Klebsiella pneumoniae and Escherichia coli isolated in hospitals in Paraguay. J Antimicrob Chemother 2009, 64:1330-1332.
41. Suzuki S, Shibata N, Yamane K, Wachino JI, Ito K, Arakawa Y: Change in the prevalence of extended-spectrum-β-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 2009, 63:72-79.
42. Pallecchi L, Bartoloni A, Fiorelli C, Mantella A, Di Maggio T, Gamboa H, Gotuzzo E, Kronvall G, Paradisi F, Rossolini GM: Rapid dissemination and diversity of CTX-M Extended-Spectrum β-Lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother 2007, 51:2720-2725.
43. Chaïbi EB, Sirot D, Paul G, Labia R: Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics. J Antimicrob Chemother 1999, 43:447-458.
44. Du bois SK, Marriott MS, Amyes SG: TEM- and SHV-derived extended-spectrum β-lactamases: relationship between selection, structure and function. J Antimicrob Chemother 1995, 35:7-22.
45. Poirel L, Decousser JW, Nordmann P: Insertion sequence ISEcp1B is involved in expression and mobilization of a blaCTX-M betalactamase gene. Antimicrob Agents Chemother 2003, 47:2938-2945.
46. Potron A, Nordmann P, Rondinaud E, Jaureguy F, Poirel L: A mosaic transposon encoding OXA-48 and CTX-M-15: towards pan-resistance. J Antimicrob Chemother 2013, 68:476-477.
47. Woodford N, Carattoli A, Karisik E, Underwood A, Ellington MJ, Livermore DM: Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M Enzymes in Three Major Escherichia coli Lineages from the United Kingdom, All Belonging to the International O25:H4-ST131 Clone. Antimicrob Agents Chemother 2009, 53:4472-4482.